CRISPR Therapeutics AG
CRSP
$43.56
-$1.97-4.33%
Weiss Ratings | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 2.10 | |||
Price History | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.23% | |||
30-Day Total Return | 0.23% | |||
60-Day Total Return | -12.68% | |||
90-Day Total Return | -8.11% | |||
Year to Date Total Return | 5.04% | |||
1-Year Total Return | -44.86% | |||
2-Year Total Return | -9.20% | |||
3-Year Total Return | -27.89% | |||
5-Year Total Return | -1.76% | |||
52-Week High % Change | -44.29% | |||
52-Week Low % Change | 24.67% | |||
Price | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $81.73 | |||
52-Week Low Price | $36.52 | |||
52-Week Low Price (Date) | Jan 13, 2025 | |||
52-Week High Price (Date) | Mar 08, 2024 | |||
Valuation | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 3.91B | |||
Enterprise Value | 2.23B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -4.37 | |||
Earnings Per Share Growth | 121.12% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 104.28 | |||
Price/Book (Q) | 2.02 | |||
Enterprise Value/Revenue (TTM) | 59.63 | |||
Price | $43.52 | |||
Enterprise Value/EBITDA (TTM) | -4.97 | |||
Enterprise Value/EBIT | -4.77 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 85.46M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 41 41 561 32 77 | |||
Address | -- | |||
Website | www.crisprtx.com | |||
Country | Switzerland | |||
Year Founded | 2013 | |||
Profitability | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -1,250.37% | |||
Profit Margin | -981.54% | |||
Management Effectiveness | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -13.04% | |||
Return on Equity | -- | |||
Income Statement | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 37.31M | |||
Total Revenue (TTM) | 37.31M | |||
Revenue Per Share | $0.44 | |||
Gross Profit (TTM) | -393.59M | |||
EBITDA (TTM) | -447.31M | |||
EBIT (TTM) | -466.57M | |||
Net Income (TTM) | -366.25M | |||
Net Income Avl. to Common (TTM) | -366.25M | |||
Total Revenue Growth (Q YOY) | -82.26% | |||
Earnings Growth (Q YOY) | -141.76% | |||
EPS Diluted (TTM) | -4.37 | |||
EPS Diluted Growth (Q YOY) | -139.88% | |||
Balance Sheet | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.90B | |||
Cash Per Share (Q) | $22.28 | |||
Total Current Assets (Q) | 1.94B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.93B | |||
Current Ratio (Q) | 22.068 | |||
Book Value Per Share (Q) | $22.53 | |||
Total Assets (Q) | 2.24B | |||
Total Current Liabilities (Q) | 87.78M | |||
Total Debt (Q) | 223.69M | |||
Total Liabilities (Q) | 309.95M | |||
Total Common Equity (Q) | 1.93B | |||
Cash Flow | CRSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -280.48M | |||
Cash from Financing (TTM) | 331.98M | |||
Net Change in Cash (TTM) | -91.29M | |||
Levered Free Cash Flow (TTM) | 99.69M | |||
Cash from Operations (TTM) | -142.77M | |||